S

Savara

D

SVRA

USD

0.21

(4.7351%)

Market Closed

48,162.00

حجم التداول

-0.455

الربح لكل سهم

-

العائد الربحي

-11.059524

P/E

764,569,800.94

حجم السوق

اليوم

4.7351%

1 اسبوع

9.681%

1 شهر

4.382%

6 اشهر

-4.424%

12 اشهر

20.806%

بداية السنة

-1.380%

كل الوقت

-99.138%

أصول ذات صلة

Title:
Savara

Sector:

Healthcare

Industry:

Biotechnology

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

هل تحتاج مساعدة او لديك استفسار؟

تواصل معنا